Results 101 to 110 of about 7,499 (195)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension

open access: yesClinical Ophthalmology, 2008
Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj  

Brimonidine Eye Drops within the Reach of Children: A Possible Foe

open access: yesChildren
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta   +5 more
doaj   +1 more source

Effects of 'Authorized-Generics' on Canadian Drug Prices [PDF]

open access: yes
This paper examines how the use of ‘authorized-generics’ (AGs) influences Canadian prescription drug prices. An authorized-generic is the actual brand name drug product, manufactured by the brand firm, but sold as a generic by a licensee or subsidiary of
Paul Grootendorst
core  

Twenty-four hour efficacy of glaucoma medications [PDF]

open access: yes, 2015
Katsanos, Andreas   +5 more
core   +1 more source

Distribution of melanopsin positive neurons in pigmented and albino mice: evidence for melanopsin interneurons in the mouse retina. [PDF]

open access: yes, 2014
Here we have studied the population of intrinsically photosensitive retinal ganglion cells (ipRGCs) in adult pigmented and albino mice. Our data show that although pigmented (C57Bl/6) and albino (Swiss) mice have a similar total number of ipRGCs, their ...
Agudo-Barriuso, M   +8 more
core  

Modification of contact lenses via metal‐organic frameworks for glaucoma treatment

open access: yesAggregate
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure. Here, human contact lenses are modified with highly porous metal‐organic frameworks with sustained release of brimonidine for prolonged glaucoma ...
Alexey V. Yaremenko   +21 more
doaj   +1 more source

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

open access: yesClinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

BRIMONIDINE EFFICACY ON INTRAOCULAR PRESSURE CONTROL FOLLOWING ND: YAG LASER CAPSULOTOMY

open access: yesPakistan Armed Forces Medical Journal, 2018
Objective: To determine the efficacy of 0.2% brimonidine eye drops on control of intraocular pressure following Neodymium: Yttrium-Aluminum-Garnet (Nd: YAG) laser posterior capsulotomy. Study Design: Quasi experimental study.
Muhammad Asaad Saleem   +4 more
doaj  

The role of brimonidine tartrate gel in the treatment of rosacea

open access: yesClinical, Cosmetic and Investigational Dermatology, 2015
J Mark Jackson,1 Melissa Knuckles,2 John Paul Minni,3 Sandra Marchese Johnson,4, Kevin Tate Belasco5 1Division of Dermatology, University of Louisville, Louisville, KY, USA; 2PSC, Dermatology, Corbin, KY, USA; 3Waters Edge Dermatology, Stuart, FL, USA ...
Jackson JM   +4 more
doaj  

Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Kölz C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy